- Preview Available
- Scholarly Journal
Intravenous liposomal irinotecan in metastatic triple-negative breast cancer after ≥ 2 prior lines of chemotherapy: a phase Ib study
Nature Communications; London Vol. 16, Iss. 1, (2025): 3.
DOI:10.1038/s41467-024-55090-4
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.